Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Curated Information Page
PubMed Id: 16908529 
This page summarizes selected information from the article referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2012,40:D261-70). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Yajima H, Lee KJ, Chen BP (2006) ATR-dependent phosphorylation of DNA-dependent protein kinase catalytic subunit in response to UV-induced replication stress. Mol Cell Biol 26, 7520-8 16908529
Only sites from this record are displayed on this page. Click on the protein name to open the protein page, and on the RSD number to open the site page. For the complete dataset, click the download button, on the right.
Download Sites

S2056-p - DNAPK (human)
Orthologous residues
DNAPK (human): S2056‑p, DNAPK (mouse): S2053‑p, DNAPK (rat): S2051‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody, western blotting
 Disease tissue studied:  bone cancer
 Relevant cell lines - cell types - tissues:  CHO (fibroblast), HeLa (cervical), HSF (fibroblast), U2OS (bone cell)
 Cellular systems studied:  cell lines
 Species studied:  hamster, human
Upstream Regulation
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
ionizing radiation increase
UV no change compared to control

T2609-p - DNAPK (human)
Orthologous residues
DNAPK (human): T2609‑p, DNAPK (mouse): T2605‑p, DNAPK (rat): T2603‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody, western blotting
 Disease tissue studied:  bone cancer
 Relevant cell lines - cell types - tissues:  CHO (fibroblast), HeLa (cervical), HSF (fibroblast), U2OS (bone cell)
 Cellular systems studied:  cell lines
 Species studied:  hamster, human
Upstream Regulation
 Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE ATR (human) pharmacological inhibitor of upstream enzyme, genetic transfer of dominant-negative enzyme, pharmacological activator of upstream enzyme, siRNA inhibition of enzyme, phospho-antibody, co-immunoprecipitation
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
ionizing radiation increase
UV increase
wortmannin UV no effect upon treatment-induced increase
caffeine UV inhibit treatment-induced increase
siRNA UV no effect upon treatment-induced increase ATM siRNA
siRNA UV inhibit treatment-induced increase ATR siRNA

T2647-p - DNAPK (human)
Orthologous residues
DNAPK (human): T2647‑p, DNAPK (mouse): T2643‑p, DNAPK (rat): T2641‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody, western blotting
 Disease tissue studied:  bone cancer
 Relevant cell lines - cell types - tissues:  CHO (fibroblast), HeLa (cervical), HSF (fibroblast), U2OS (bone cell)
 Cellular systems studied:  cell lines
 Species studied:  hamster, human
Upstream Regulation
 Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE ATR (human) pharmacological inhibitor of upstream enzyme, genetic transfer of dominant-negative enzyme, pharmacological activator of upstream enzyme, siRNA inhibition of enzyme, phospho-antibody, co-immunoprecipitation
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
ionizing radiation increase
UV increase
wortmannin UV no effect upon treatment-induced increase
caffeine UV inhibit treatment-induced increase
siRNA UV no effect upon treatment-induced increase ATM siRNA
siRNA UV inhibit treatment-induced increase ATR siRNA


Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.